Sichuan Biokin Hits Day High with Strong 3.17% Intraday Surge

Sichuan Biokin Pharmaceutical Co., Ltd. has experienced a notable uptick in its stock performance, gaining 3.17% on March 16, 2026. The stock reached an intraday high of CNY 268.00, reflecting a strong day of trading for the large-cap company within the Pharmaceuticals & Biotechnology sector. In comparison to the broader market, Sichuan Biokin's one-day performance stands out against the China Shanghai Composite, which saw a decline of 0.26%. Over the past week, the stock has shown resilience with a 4.09% increase, while its year-to-date performance remains down by 17.83%. Despite recent fluctuations, Sichuan Biokin has demonstrated a robust annual growth rate of 25.22%, outperforming the China Shanghai Composite's 19.45% over the same period. However, the company has faced challenges, including negative net sales and profit figures in recent quarters. With a market capitalization of CNY 29,530 million, Sichuan Biokin continues to navigate a complex financial landscape, marked by significant historical returns over the past three years.